Abstract
Definition: Benign cartilaginous tumor made of lobulated, fibromyxoid, and chondroid tissue.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Definition: Benign cartilaginous tumor made of lobulated, fibromyxoid, and chondroid tissue.
Epidemiology: It is definitely rare (0.5 % of all bone tumors, about 2 % of all benign neoplasms) and prefers the male sex by 1.5–1. Generally seen between 5 and 30 years of age, it has a predilection for the second and third decades of life.
Location: Typically located in the long bone metaphysis, it can invade the epiphysis, especially in adults. Preferred sites proximal tibia (30 % of cases), small bones of the foot, and pelvis. Rare in the upper limb and in the trunk besides pelvis.
Clinical: Long-standing mild to moderate pain sometimes associated with bland local swelling is the typical scenario, because of the rather slow growth. Occasionally asymptomatic and discovered as incidental finding on roentgenograms.
Imaging: Small (generally <5 cm), metaphyseal, and eccentric radiolucent defect, usually with the long axis parallel to the bone of origin and occupying one half to two thirds of the diameter of the shaft; sometimes, especially in small bones, fusiform expansion of its entire contour. Sharply marginated by a lobulated shell of endosteal reactive bone because of a sclerotic rim. The cortex is usually canceled, with the tumor “bubbling out” into soft tissue. Little and peripheral periosteal reaction, chronic in nature and similar to that of periosteal chondroma. Intratumoral calcification is unusual. Isotope scan: moderately hot and corresponding to radiographic extent. CT: metaphyseal, eccentric, and subperiosteal, heavily marginated radiolucency, usually without any mineralization. MRI: homogenous intratumoral signal.
Histopathology: Gross: the tumor is rubbery soft, distinctly lobular, and clearly separated from the surrounding bone. Tissue is whitish or bluish and semitranslucent in chondromyxoid areas, tannish red in the undifferentiated and vascularized zones. Histology: lobular pattern better appreciated at low power, a light center, and a dark periphery. Basic elements stellate cells (blue) and myxoid background; center of lobule is hypocellular, periphery hypercellular. While the smaller lobules are exclusively or prevalently dark, the larger lobules are predominantly light, the dark part being limited to a narrow layer at the periphery of the lobules and in between them. These dark bands are absent where the lobules fuse together. Mitotic figures are not common. Cellular atypia may be present (15–20 % of cases). Occasionally, chondroblastoma-like cells at periphery.
Course and Stage: The tumor grows slowly and is generally small, at presentation usually stage 2 and occasionally stage 3. Few reports of malignant transformation.
Treatment: Aggressive curettage is usually indicated and frequently curative for either stage 2 and stage 3 tumors; recurrence rate probably lower than GCT and chondroblastoma. Consider en bloc resection for recurrent lesions and expendable bones.
FormalPara Key PointsClinical | Mild symptoms |
Radiological | Lobulated, subperiosteal lytic lesion |
Histological | Lobules of myxoid cartilage surrounded by more cellular bundles with vessels |
Differential diagnosis | Histiocytic fibroma (at imaging) |
Selected Bibliography
Gherlinzoni F, Rock M, Picci P (1983) Chondromyxoid fibroma. The experience at the Istituto Ortopedico Rizzoli. J Bone Joint Surg Am 65(2):198–204
Lersundi A, Mankin HJ, Mourikis A, Hornicek FJ (2005) Chondromyxoid fibroma: a rarely encountered and puzzling tumor. Clin Orthop Relat Res 439:171–175
Romeo S, Duim RA, Bridge JA, Mertens F, de Jong D, Dal Cin P, Wijers-Koster PM, Debiec-Rychter M, Sciot R, Rosenberg AE, Szuhai K, Hogendoorn PC (2010) Heterogeneous and complex rearrangements of chromosome arm 6q in chondromyxoid fibroma: delineation of breakpoints and analysis of candidate target genes. Am J Pathol 177(3):1365–1376
Wu CT, Inwards CY, O'Laughlin S, Rock MG, Beabout JW, Unni KK (1998) Chondromyxoid fibroma of bone: a clinicopathologic review of 278 cases. Hum Pathol 29(5):438–446
Zustin J, Akpalo H, Gambarotti M, Priemel M, Rueger JM, Luebke AM, Reske D, Lange C, Pueschel K, Lohmann C, Rüther W, Amling M, Alberghini M (2010) Phenotypic diversity in chondromyxoid fibroma reveals differentiation pattern of tumor mimicking fetal cartilage canals development: an immunohistochemical study. Am J Pathol 177(3):1072–1078
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Ferraro, A. (2014). Chondromyxoid Fibroma. In: Picci, P., Manfrini, M., Fabbri, N., Gambarotti, M., Vanel, D. (eds) Atlas of Musculoskeletal Tumors and Tumorlike Lesions. Springer, Cham. https://doi.org/10.1007/978-3-319-01748-8_23
Download citation
DOI: https://doi.org/10.1007/978-3-319-01748-8_23
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-01747-1
Online ISBN: 978-3-319-01748-8
eBook Packages: MedicineMedicine (R0)